New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
05:53 EDTALXNAlexion price target raised to $205 from $125 at Deutsche Bank
Deutsche Bank raised its price target for shares of Alexion Pharmaceuticals to $205 citing upside potential from the company's launch of Asfotase Alfa for severe Hypophosphatasia. The firm keeps a Buy rating on the stock.
News For ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
15:08 EDTALXNNotable companies reporting before tomorrow's open
Subscribe for More Information
July 28, 2015
07:20 EDTALXNBrookings Institute to hold a public meeting
Subscribe for More Information
July 27, 2015
08:38 EDTALXNAnalysts divided on Biogen following $85 selloff
Subscribe for More Information
06:28 EDTALXNAlexion resumed with an Overweight at JPMorgan
Target $249.
July 22, 2015
09:28 EDTALXNBiogen downgraded to Neutral at Piper Jaffray after Alzheimer's data
Subscribe for More Information
July 21, 2015
07:05 EDTALXNOphthotech names Shima as Chief Scientific Officer, Bjarke as CCO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use